Zigmantas Toleikis

Dr. Zigmantas Toleikis

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZTZigmantas Toleikis
Zigmantas Toleikis
MZMantas Ziaunys
Mantas Ziaunys
LBLina Baranauskiene
Lina Baranauskiene
VPVytautas Petrauskas
Vytautas Petrauskas
Kristaps JaudzemsKristaps Jaudzems
Kristaps Jaudzems
Vytautas SmirnovasVytautas Smirnovas
Vytautas Smirnovas
The formation of amyloid fibril plaques in the brain creates inflammation and neuron death. This process is observed in neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases. Alpha-synuclein is the main protein found in neuronal inclusions of patients who have suffered from Parkinson’s disease. S100A9 is a calcium-binding, pro-inflammation protein, which is also found in such amyloid plaques. To understand the influence of S100A9 on the aggregation of α-synuclein, we analyzed their co-aggregation kinetics and the resulting amyloid fibril structure by Fourier-transform infrared spectroscopy and atomic force microscopy. We found that the presence of S100A9 alters the aggregation kinetics of α-synuclein and stabilizes the formation of a particular amyloid fibril structure. We also show that the solution’s ionic strength influences the interplay between S100A9 and α-synuclein, stabilizing a different structure of α-synuclein fibrils.

Verified
Journal Article
Open access
PDF file
ZTZigmantas Toleikis
Zigmantas Toleikis
RBRaitis Bobrovs
Raitis Bobrovs
AJAgne Janoniene
Agne Janoniene
ALAlons Lends
Alons Lends
MZMantas Ziaunys
Mantas Ziaunys
Kristaps JaudzemsKristaps Jaudzems
Kristaps Jaudzems
S100A9 is a pro-inflammatory protein that co-aggregates with other proteins in amyloid fibril plaques. S100A9 can influence the aggregation kinetics and amyloid fibril structure of alpha-synuclein (α-syn), which is involved in Parkinson’s disease. Currently, there are limited data regarding their cross-interaction and how it influences the aggregation process. In this work, we analyzed this interaction using solution 19F and 2D 15N–1H HSQC NMR spectroscopy and studied the aggregation properties of these two proteins. Here, we show that α-syn interacts with S100A9 at specific regions, which are also essential in the first step of aggregation. We also demonstrate that the 4-fluorophenylalanine label in alpha-synuclein is a sensitive probe to study interaction and aggregation using 19F NMR spectroscopy.

Verified
Journal Article
Open access
PDF file
JFJēkabs Fridmanis
Jēkabs Fridmanis
ZTZigmantas Toleikis
Zigmantas Toleikis
TŠTomas Šneideris
Tomas Šneideris
MZMantas Ziaunys
Mantas Ziaunys
RBRaitis Bobrovs
Raitis Bobrovs
Kristaps JaudzemsKristaps Jaudzems
Kristaps Jaudzems
Prion diseases are associated with conformational conversion of cellular prion protein into a misfolded pathogenic form, which resembles many properties of amyloid fibrils. The same prion protein sequence can misfold into different conformations, which are responsible for variations in prion disease phenotypes (prion strains). In this work, we use atomic force microscopy, FTIR spectroscopy and magic-angle spinning NMR to devise structural models of mouse prion protein fibrils prepared in three different denaturing conditions. We find that the fibril core region as well as the structure of its N- and C-terminal parts is almost identical between the three fibrils. In contrast, the central part differs in length of β-strands and the arrangement of charged residues. We propose that the denaturant ionic strength plays a major role in determining the structure of fibrils obtained in a particular condition by stabilizing fibril core interior-facing glutamic acid residues.